Global Enzyme-Linked Immunosorbent Assay (ELISA) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
Description
According to our (Global Info Research) latest study, the global Enzyme-Linked Immunosorbent Assay (ELISA) market size was valued at US$ 1912 million in 2025 and is forecast to a readjusted size of US$ 2519 million by 2032 with a CAGR of 4.1% during review period.
ELISA Kit (enzyme-linked immunosorbent assay) is the most widely used technology in enzyme immunoassay technology. Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. ELISA kit involve attachment of a capture antibody to a solid phase support. Samples containing known or unknown antigen are then added in a matrix or buffer that will minimize attachment to the solid phase. An enzyme-labeled antibody is then added for detection. Enzyme-linked immunosorbent assay (ELISA) is an analytical, plate-based technique to detect and quantify the presence of an target analyte in a liquid sample using antibodies.
The Enzyme-Linked Immunosorbent Assay (ELISA) market is growing steadily, driven by its wide application in diagnostics, research, and quality control. ELISA is a highly sensitive and specific immunoassay used to detect and quantify proteins, hormones, antibodies, and pathogens in biological samples. It plays a critical role in clinical diagnostics for infectious diseases, autoimmune disorders, and cancer biomarkers, as well as in drug development and pharmaceutical research. Its ability to process multiple samples simultaneously, coupled with cost-effectiveness and compatibility with automation, makes ELISA a preferred choice for laboratories worldwide.
Market growth is further fueled by the increasing demand for early disease detection, advancements in immunodiagnostic technologies, and rising investment in life sciences research. The technique is also being adapted for use in point-of-care testing and high-throughput screening, improving its utility across healthcare and biotechnology sectors. However, challenges such as the risk of cross-reactivity, the need for skilled personnel, and competition from advanced molecular diagnostic tools like PCR and next-generation sequencing can limit adoption in certain areas. Despite these hurdles, ongoing innovations in assay formats and detection systems ensure that ELISA remains a cornerstone technology in both clinical and research settings.
This report is a detailed and comprehensive analysis for global Enzyme-Linked Immunosorbent Assay (ELISA) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Enzyme-Linked Immunosorbent Assay (ELISA) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enzyme-Linked Immunosorbent Assay (ELISA)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enzyme-Linked Immunosorbent Assay (ELISA) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Enzo Life Sciences, BioLegend, Merck, Bio-Techne, BD Biosciences, Bio-Rad Laboratorie, Aviva Systems Biology, Repligen, Lifespan Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Enzyme-Linked Immunosorbent Assay (ELISA) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Indirect ELISA
Sandwich ELISA
Competitive ELISA
Others
Market segment by Application
Laboratory
Testing Institutions
Hospital
Others
Major players covered
Thermo Fisher Scientific
Enzo Life Sciences
BioLegend
Merck
Bio-Techne
BD Biosciences
Bio-Rad Laboratorie
Aviva Systems Biology
Repligen
Lifespan Biosciences
PerkinElmer
BioVision
Innovative Research
Biomatik
Shanghai Kehua Bio-Engineering
Biomerieux
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Enzyme-Linked Immunosorbent Assay (ELISA) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Enzyme-Linked Immunosorbent Assay (ELISA), with price, sales quantity, revenue, and global market share of Enzyme-Linked Immunosorbent Assay (ELISA) from 2021 to 2026.
Chapter 3, the Enzyme-Linked Immunosorbent Assay (ELISA) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enzyme-Linked Immunosorbent Assay (ELISA) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Enzyme-Linked Immunosorbent Assay (ELISA) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Enzyme-Linked Immunosorbent Assay (ELISA).
Chapter 14 and 15, to describe Enzyme-Linked Immunosorbent Assay (ELISA) sales channel, distributors, customers, research findings and conclusion.
ELISA Kit (enzyme-linked immunosorbent assay) is the most widely used technology in enzyme immunoassay technology. Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. ELISA kit involve attachment of a capture antibody to a solid phase support. Samples containing known or unknown antigen are then added in a matrix or buffer that will minimize attachment to the solid phase. An enzyme-labeled antibody is then added for detection. Enzyme-linked immunosorbent assay (ELISA) is an analytical, plate-based technique to detect and quantify the presence of an target analyte in a liquid sample using antibodies.
The Enzyme-Linked Immunosorbent Assay (ELISA) market is growing steadily, driven by its wide application in diagnostics, research, and quality control. ELISA is a highly sensitive and specific immunoassay used to detect and quantify proteins, hormones, antibodies, and pathogens in biological samples. It plays a critical role in clinical diagnostics for infectious diseases, autoimmune disorders, and cancer biomarkers, as well as in drug development and pharmaceutical research. Its ability to process multiple samples simultaneously, coupled with cost-effectiveness and compatibility with automation, makes ELISA a preferred choice for laboratories worldwide.
Market growth is further fueled by the increasing demand for early disease detection, advancements in immunodiagnostic technologies, and rising investment in life sciences research. The technique is also being adapted for use in point-of-care testing and high-throughput screening, improving its utility across healthcare and biotechnology sectors. However, challenges such as the risk of cross-reactivity, the need for skilled personnel, and competition from advanced molecular diagnostic tools like PCR and next-generation sequencing can limit adoption in certain areas. Despite these hurdles, ongoing innovations in assay formats and detection systems ensure that ELISA remains a cornerstone technology in both clinical and research settings.
This report is a detailed and comprehensive analysis for global Enzyme-Linked Immunosorbent Assay (ELISA) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Enzyme-Linked Immunosorbent Assay (ELISA) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enzyme-Linked Immunosorbent Assay (ELISA)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enzyme-Linked Immunosorbent Assay (ELISA) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Enzo Life Sciences, BioLegend, Merck, Bio-Techne, BD Biosciences, Bio-Rad Laboratorie, Aviva Systems Biology, Repligen, Lifespan Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Enzyme-Linked Immunosorbent Assay (ELISA) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Indirect ELISA
Sandwich ELISA
Competitive ELISA
Others
Market segment by Application
Laboratory
Testing Institutions
Hospital
Others
Major players covered
Thermo Fisher Scientific
Enzo Life Sciences
BioLegend
Merck
Bio-Techne
BD Biosciences
Bio-Rad Laboratorie
Aviva Systems Biology
Repligen
Lifespan Biosciences
PerkinElmer
BioVision
Innovative Research
Biomatik
Shanghai Kehua Bio-Engineering
Biomerieux
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Enzyme-Linked Immunosorbent Assay (ELISA) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Enzyme-Linked Immunosorbent Assay (ELISA), with price, sales quantity, revenue, and global market share of Enzyme-Linked Immunosorbent Assay (ELISA) from 2021 to 2026.
Chapter 3, the Enzyme-Linked Immunosorbent Assay (ELISA) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enzyme-Linked Immunosorbent Assay (ELISA) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Enzyme-Linked Immunosorbent Assay (ELISA) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Enzyme-Linked Immunosorbent Assay (ELISA).
Chapter 14 and 15, to describe Enzyme-Linked Immunosorbent Assay (ELISA) sales channel, distributors, customers, research findings and conclusion.
Table of Contents
140 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Enzyme-Linked Immunosorbent Assay (ELISA) by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
